Vanguard Group
TTOO

Vanguard Group’s T2 Biosystems, Inc TTOO Stock Holding History

Vanguard Group’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-154,814
Closed -$65K – 4356
2024
Q4 		$65K Sell
154,814
-235,554
-60% -$197K ﹤0.01% 4194
2024
Q3 		$769K Buy
390,368
+77,667
+25% +$295K ﹤0.01% 3850
2024
Q2 		$1.67M Buy
312,701
+267,006
+584% +$1.11M ﹤0.01% 3618
2024
Q1 		$137K Hold
45,695
– – ﹤0.01% 4215
2023
Q4 		$287K Sell
45,695
-13,127
-22% -$100K ﹤0.01% 4165
2023
Q3 		$1.3M Buy
+58,822
New +$1.53M ﹤0.01% 3739
2023
Q2 		– Sell
-1,323
Closed -$60.9K – 4580
2023
Q1 		$60.9K Sell
1,323
-431
-25% -$47K ﹤0.01% 4452
2022
Q4 		$249K Sell
1,754
-64
-4% -$13.1K ﹤0.01% 4265
2022
Q3 		$1.03M Hold
1,818
– – ﹤0.01% 3991
2022
Q2 		$1.47M Buy
1,818
+813
+81% +$1.2M ﹤0.01% 3948
2022
Q1 		$2.63M Sell
1,005
-331
-25% -$703K ﹤0.01% 3844
2021
Q4 		$3.45M Buy
1,336
+30
+2% +$104K ﹤0.01% 3807
2021
Q3 		$5.98M Buy
1,306
+3
+0.2% +$15.1K ﹤0.01% 3537
2021
Q2 		$7.76M Sell
1,303
-1
-0.1% -$6.46K ﹤0.01% 3345
2021
Q1 		$10.6M Buy
1,304
+67
+5% +$710K ﹤0.01% 3112
2020
Q4 		$7.67M Buy
1,237
+164
+15% +$1M ﹤0.01% 3139
2020
Q3 		$7.3M Buy
1,073
+121
+13% +$897K ﹤0.01% 2959
2020
Q2 		$6.04M Buy
952
+510
+115% +$2.17M ﹤0.01% 3018
2020
Q1 		$1.44M Buy
442
+143
+48% +$594K ﹤0.01% 3391
2019
Q4 		$1.75M Hold
299
– – ﹤0.01% 3488
2019
Q3 		$3.73M Buy
299
+21
+8% +$169K ﹤0.01% 3242
2019
Q2 		$2.34M Buy
278
+47
+20% +$551K ﹤0.01% 3430
2019
Q1 		$3.04M Buy
231
+71
+44% +$1.21M ﹤0.01% 3319
2018
Q4 		$2.41M Sell
160
-164
-51% -$3.85M ﹤0.01% 3317
2018
Q3 		$12.1M Buy
324
+25
+8% +$823K ﹤0.01% 2826
2018
Q2 		$11.6M Buy
299
+108
+57% +$4.1M ﹤0.01% 2830
2018
Q1 		$6.21M Buy
191
+40
+26% +$1.08M ﹤0.01% 3055
2017
Q4 		$3.11M Buy
151
+47
+45% +$970K ﹤0.01% 3293
2017
Q3 		$2.18M Sell
104
-14
-12% -$260K ﹤0.01% 3368
2017
Q2 		$1.89M Sell
118
-12
-9% -$240K ﹤0.01% 3399
2017
Q1 		$3.41M Buy
130
+5
+4% +$141K ﹤0.01% 3199
2016
Q4 		$3.3M Buy
125
+7
+6% +$216K ﹤0.01% 3193
2016
Q3 		$4.25M Buy
118
+16
+16% +$526K ﹤0.01% 3089
2016
Q2 		$4.04M Buy
102
+6
+6% +$271K ﹤0.01% 3080
2016
Q1 		$4.72M Buy
96
+8
+9% +$353K ﹤0.01% 2982
2015
Q4 		$4.82M Buy
88
+9
+11% +$486K ﹤0.01% 3003
2015
Q3 		$3.47M Buy
79
+25
+46% +$1.66M ﹤0.01% 3136
2015
Q2 		$4.41M Buy
54
+19
+54% +$1.65M ﹤0.01% 3068
2015
Q1 		$2.69M Buy
35
+4
+13% +$371K ﹤0.01% 3283
2014
Q4 		$2.96M Buy
31
+5
+19% +$412K ﹤0.01% 3133
2014
Q3 		$2.39M Buy
+26
New +$2.42M ﹤0.01% 3192

Vanguard Group's TTOO Position: Q1 2025 in Review

Vanguard Group sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 154,814 shares — an estimated $65K sold.

Vanguard Group first reported a position in TTOO in Q3 2014 and held it in 41 quarters. The position peaked at $12.1M in Q3 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.

  • Vanguard Group reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
  • Vanguard Group sold 154,814 T2 Biosystems, Inc shares in Q1 2025, an estimated $65K.
  • Vanguard Group first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 41 quarters.
  • Vanguard Group's T2 Biosystems, Inc position peaked at $12.1M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.

Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.